Evidence map›Paper›PMID 39520401›Full record

ArticleBioinformatics (Oxford, England)2024

p-IgGen: a paired antibody generative language model.

Oliver M Turnbull, Dino Oglic, Rebecca Croasdale-Wood, Charlotte M Deane

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. A comprehensive overview of recent advances in generative models for antibodies.Computational and structural biotechnology journal · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Oliver M TurnbullDepartment of Statistics, University of Oxford, Oxford, OX1 3LB, United Kingdom.ORCID 0000-0002-0239-1207
Dino OglicCentre for AI, Biopharmaceuticals R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom.
Rebecca Croasdale-WoodBiologics Engineering, Oncology R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom.
Charlotte M DeaneDepartment of Statistics, University of Oxford, Oxford, OX1 3LB, United Kingdom.ORCID 0000-0003-1388-2252

Funding

UK Engineering and Physical Sciences Research Council
6 · The paper itself

Abstract

summaryA key challenge in antibody drug discovery is designing novel sequences that are free from developability issues-such as aggregation, polyspecificity, poor expression, or low solubility. Here, we present p-IgGen, a protein language model for paired heavy-light chain antibody generation. The model generates diverse, antibody-like sequences with pairing properties found in natural antibodies. We also create a finetuned version of p-IgGen that biases the model to generate antibodies with 3D biophysical properties that fall within distributions seen in clinical-stage therapeutic antibodies. AVAILABILITY AND IMPLEMENTATION: The model and inference code are freely available at www.github.com/oxpig/p-IgGen. Cleaned training data are deposited at doi.org/10.5281/zenodo.13880874.

Indexed as

AntibodiesDrug DiscoveryHumansSoftwareAntibodies

Identifiers

PMID39520401
PMCPMC11576349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.